Paper Details

  1. Home
  2. Paper Details

Secondary and Exploratory Outcomes of the Subthreshold Nanosecond Laser Intervention Randomized Trial in Age-Related Macular Degeneration: A LEAD Study Report.

Author: , ArnoldJennifer J, AungKhin Zaw, BaglinElizabeth K, BrassingtonKate H, CarusoEmily, ChakravarthyUsha, ChenFred K, CohnAmy C, DurkinShane R, FingerRobert P, Gorgi ZadehShekoufeh, GuymerRobyn H, HarperColin A, HeriotWilson J, HodgsonLauren A B, LuuChi D, McGuinnessMyra B, SandhuSukhpal S, SchultzThomas, SharanganPyrawy, TindillNicole, WickremasingheSanjeewa S, WintergerstMaximilian W M, WuZhichao

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study evaluated the secondary and exploratory outcomes of the Laser Intervention in Early Stages of Age-Related Macular Degeneration (LEAD) study, which investigated the use of subthreshold nanosecond laser (SNL) treatment for slowing the progression of age-related macular degeneration (AMD).
Paper Details　
Original Abstract of the Article :
To evaluate the secondary and exploratory outcomes of the Laser Intervention in Early Stages of Age-Related Macular Degeneration (LEAD) study, a 36-month trial of a subthreshold nanosecond laser (SNL) treatment for slowing the progression to late age-related macular degeneration (AMD) in its early s...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.oret.2019.07.008

データ提供：米国国立医学図書館（NLM）

A New Light on Age-Related Macular Degeneration: Navigating the Desert of Vision Loss

The quest for effective treatments for age-related macular degeneration (AMD) is a journey through a desert of vision loss, with researchers constantly seeking new ways to slow or halt the progression of this debilitating condition. This study delves into the secondary and exploratory outcomes of a 36-month trial of a subthreshold nanosecond laser (SNL) treatment for early-stage AMD, exploring its potential to slow the progression to late-stage disease.

A Glimmer of Hope: The Potential of SNL Treatment

The study's findings provide a glimmer of hope, demonstrating that SNL treatment may offer potential benefits in slowing the progression of AMD. It's like discovering a hidden oasis in the vast desert, offering a haven from the relentless march of vision loss.

A New Path Forward: Exploring the Possibilities for AMD Treatment

This research underscores the importance of ongoing research into novel treatment approaches for AMD. It highlights the potential of SNL treatment as a promising avenue for exploration, potentially offering new options for patients battling vision loss. This is a testament to the spirit of exploration and the relentless pursuit of new solutions in the face of challenging medical conditions.

Dr. Camel's Conclusion

This study offers a glimmer of hope in the battle against age-related macular degeneration, exploring the potential of subthreshold nanosecond laser treatment as a promising avenue for slowing the progression of this debilitating disease. It reinforces the importance of ongoing research to discover new treatments and improve the lives of those affected by vision loss.

Date :
  1. Date Completed 2020-10-14
  2. Date Revised 2020-10-14
Further Info :

Pubmed ID

31582304

DOI: Digital Object Identifier

10.1016/j.oret.2019.07.008

Related Literature

Article Analysis
・Effective treatment of macular degeneration
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.